5-Chloro-N4-(4-fluorobenzyl)-N2-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidine-2,4-diamine

ID: ALA4649116

PubChem CID: 155665828

Max Phase: Preclinical

Molecular Formula: C21H23ClFN7

Molecular Weight: 427.92

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(Nc3ncc(Cl)c(NCc4ccc(F)cc4)n3)nc2)CC1

Standard InChI:  InChI=1S/C21H23ClFN7/c1-29-8-10-30(11-9-29)17-6-7-19(24-13-17)27-21-26-14-18(22)20(28-21)25-12-15-2-4-16(23)5-3-15/h2-7,13-14H,8-12H2,1H3,(H2,24,25,26,27,28)

Standard InChI Key:  MOYSDHLSIFKCBQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   20.6223  -10.4047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6212  -11.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3292  -11.6332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0389  -11.2238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0361  -10.4011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3275   -9.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7473  -11.6313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7422   -9.9898    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.9132  -11.6323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2058  -11.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2110  -10.4061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5044   -9.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7954  -10.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7974  -11.2265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5045  -11.6319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0875   -9.9969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0870   -9.1797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3800  -10.4058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6721   -9.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3791   -8.7714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6716   -9.1804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9637   -8.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4543  -11.2215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1627  -11.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1593  -12.4447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8668  -12.8521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5749  -12.4423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5710  -11.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8629  -11.2172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2838  -12.8489    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  5  8  1  0
  2  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 17 20  1  0
 19 21  1  0
 21 20  1  0
 21 22  1  0
  7 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4649116

    ---

Associated Targets(Human)

CCND3 Tchem CDK6/cyclin D3 (897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK9 Tchem CDK9/Cyclin K (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.92Molecular Weight (Monoisotopic): 427.1687AlogP: 3.77#Rotatable Bonds: 6
Polar Surface Area: 69.21Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.69CX Basic pKa: 7.65CX LogP: 4.04CX LogD: 3.60
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.62Np Likeness Score: -1.82

References

1. Wang Y, Chen X, Yan Y, Zhu X, Liu M, Liu X..  (2020)  Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity.,  63  (6): [PMID:32129996] [10.1021/acs.jmedchem.9b02121]

Source